Encompass Health Corp — Form 10-Q
Filed November 3, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Mark J. Tarr (CEO) and Douglas E. Coltharp (CFO) certified the Form 10-Q for period ended September 30, 2026, on November 3, 2026, attesting that financial statements fairly present the company's condition and results. The filing includes a comprehensive list of 200+ subsidiary guarantors (rehabilitation hospitals, real estate entities, and holding companies) that guarantee Encompass Health's senior unsecured notes. No financial data, dollar amounts, or material changes are disclosed in these exhibits.
Why this rating
Routine Sarbanes-Oxley certifications and boilerplate subsidiary disclosure. No new business events, financial changes, or material developments disclosed. Standard periodic compliance filing.
See more from November 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.